Micronutrient Deficiencies

T. Dierks | I. Harting | J. Hellemans | M. Gheorghiade | M. Metra | S. Anker | T. Haferlach | P. Giampietro | G. Fonarow | S. Rudnik-Schöneborn | J. Cleland | K. Figura | K. Jurkat-Rott | C. Haferlach | W. Hul | B. Grandchamp | J. Schulzke | D. Cilloni | M. Riemenschneider | D. Engman | A. Sperfeld | F. Marini | N. Darín | V. Gieselmann | C. Sewry | J. Ezekowitz | J. Bubeník | E. Pasini | G. Almogy | B. Udd | M. Sole | A. Falchetti | R. Yaou | J. Šímová | C. Galliani | P. C. Issa | V. Oji | H. Gdynia | A. Bleyer | D. Prié | R. Hämäläinen | M. Merrer | M. Schiller | A. G. Engel | T. Strzelczyk | L. J. Mienie | P. Hackman | M. Schmitt | B. Kone | H. R. Hegde | M. Lipsanen-Nyman | T. Suominen | V. Soukoulis | C. Plesa | A. Rozelle | C. Dejthevaporn | Naoto Kuroda | J. Schnog | Bernhard Schmidt | R. Quinlivan | D. Zand | Jamil B. Dihu | J. Logan | Heinrich | S. Makoni | J. Uhl | Arndt Hartmann | S. Hofmann | Elardus Erasmus | U. Knirsch | J. Finley | D. Liolitsa | Siobhan D. Ma | Patrick T. S. Ma | Benjamin D. Tyrrell | D. Récan-Budiartha | Tommie V. McCarthy | P. Schwarz | R. Sauve | S. Fontaine | R. Sabina | W. Wuyts | Jiang Li | M. Melaragno | K. Bonney | Cengiz Korkmaz | Michael Beck | E. Hoffman | Alexander A. C. Leung | M. Galera | M. Duran | Gisèle Bonne | Markus Pfister | Olaf Strauss | Stephan Grabbe | Jürgen Kopitz | Nicole Wolf | Thomas C. Hart | Michele Bisceglia | G. Mortier | Julian F.B. Mercer | Ingrid Moll | K. Beyer | Thorsten Buch | Shirley Hodgson | Bernadette McGuinness | Yukichi Goto | Christine Liang | E. Sibley | Michael Briggs | G. Enzi | W. Kempf | Deepak Kamat | T. Gasser | O. Raheem | F. Lehmann‐Horn | Lucia K. Ma | I. Förster | Jürgen Grabbe | Susanne Schnittger | F. Holz | A. Lehesjoki | H. Scholl | Hans-Peter Zenner | Holger Sudhoff | Wolfgang Dietmaier | Monika Fleckenstein | S. Schmitz-Valckenberg | Hayrettin Tumani | Michael Fromm | Constantine A. Stratakis | P. J. Goadsby | Peter Bärtsch | J. Fong | Hannu Jalanko | C. Sunderkötter | Guido Reifenberger | Stefan R. Bornstein | E. Zackai | G. Saglio | G. Hadjigeorgiou | Ioannis Stefanidis | J. Finsterer | Frank Schaeffel | Heimo Mairbäurl | Damian M. Bailey | Mark Oette | Avraham I. Rivkind | Eliza F. Chakravarty | Michael Cantz | Klaus Zerres | Thomas Klockgether | Wolfgang Schillinger | Filip Vanhoenacker | V. Gerdes | G. Hasenfuss | A. Schulz | Leena Bruckner‐Tuderman | Anders Oldfors | M. L. Brandi | S. Dahl | Caroline Silve | Friedrich Asmus | W. Robson | U. Bacher | Christian A. Koch | Gisela Stoltenburg-Didinger | S. Schinner | Gérard Friedlander | T. Klopstock | Toshio Nishikimi | Reinhardt Dummer | G. Burg | H. Traupe | D. Metze | R. Beynon | L. Busetto | David Geneviève | Tommy Martinsson | Marvin J. Stone | Hideaki Kato | S. Pfister | Olaf Witt | Maria Judit Molnar | Michael G. Hanna | Julie V. Schaffer | Franck E Nicolini | Ulrich S. Schuler

[1]  H. Leong-Poi,et al.  B-vitamin deficiency in hospitalized patients with heart failure. , 2009, Journal of the American Dietetic Association.

[2]  M. Gheorghiade,et al.  Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.

[3]  K. Weber,et al.  Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. , 2008, Cardiovascular research.

[4]  D. Stewart,et al.  Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  C. Opasich,et al.  Adequate energy‐protein intake is not enough to improve nutritional and metabolic status in muscle‐depleted patients with chronic heart failure , 2008, European journal of heart failure.

[6]  R. Ferrari,et al.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[7]  Javed Butler,et al.  Worsening heart failure hospitalization epidemic we do not know how to prevent and we do not know how to treat! , 2008, Journal of the American College of Cardiology.

[8]  George A Mensah,et al.  Heart failure-related hospitalization in the U.S., 1979 to 2004. , 2008, Journal of the American College of Cardiology.

[9]  M. Gheorghiade,et al.  More than bricks and mortar: comments on protein and amino acid metabolism in the heart. , 2008, The American journal of cardiology.

[10]  G. D’Antona,et al.  Morphometric changes induced by amino acid supplementation in skeletal and cardiac muscles of old mice. , 2008, The American journal of cardiology.

[11]  C. Opasich,et al.  Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. , 2008, The American journal of cardiology.

[12]  R. Scognamiglio,et al.  Impairment in walking capacity and myocardial function in the elderly: is there a role for nonpharmacologic therapy with nutritional amino acid supplements? , 2008, The American journal of cardiology.

[13]  M. Ikawa,et al.  Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. , 2008, Journal of molecular and cellular cardiology.

[14]  L. Carbone,et al.  Vitamin D and calcium dyshomoeostasis-associated heart failure , 2008, Heart.

[15]  Sanjiv J. Shah,et al.  Normalization of Ejection Fraction and Resolution of Symptoms in Chronic Severe Heart Failure is Possible With Modern Medical Therapy: Clinical Observations in 11 Patients , 2008, American journal of therapeutics.

[16]  G. Fonarow,et al.  Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. , 2008, Journal of cardiac failure.

[17]  C. Frampton,et al.  Coenzyme Q 10 An Independent Predictor of Mortality in Chronic Heart Failure , 2008 .

[18]  L. Tavazzi,et al.  Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. , 2008, Lancet.

[19]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[20]  C. O'connor,et al.  Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. , 2007, JAMA.

[21]  K. Okumura,et al.  Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation , 2007, Hypertension.

[22]  M. Burch,et al.  Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure , 2007, Heart.

[23]  M. Brosnan,et al.  Creatine: endogenous metabolite, dietary, and therapeutic supplement. , 2007, Annual review of nutrition.

[24]  Gian Paolo Littarru,et al.  Bioenergetic and Antioxidant Properties of Coenzyme Q10: Recent Developments , 2007, Molecular biotechnology.

[25]  D. Sica.  Loop diuretic therapy, thiamine balance, and heart failure. , 2007, Congestive heart failure.

[26]  J. Gangoiti,et al.  Analysis of coenzyme Q in human blood and tissues. , 2007, Mitochondrion.

[27]  P. Razeghi,et al.  Return to the fetal gene program protects the stressed heart: a strong hypothesis , 2007, Heart Failure Reviews.

[28]  G. Scalia,et al.  Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with life-threatening cardiomyopathy. , 2007, Heart, lung & circulation.

[29]  K. Swedberg,et al.  Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. , 2007, JAMA.

[30]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[31]  Min Zhang,et al.  Role of reactive oxygen species in myocardial remodeling , 2007, Current heart failure reports.

[32]  H. Krum,et al.  Coenzyme Q 10 in cardiovascular disease , 2007 .

[33]  H. Smithline.  Thiamine for the treatment of acute decompensated heart failure. , 2007, The American journal of emergency medicine.

[34]  J. Ingwall.  On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine , 2006, Current hypertension reports.

[35]  Robert G. Weiss,et al.  Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium , 2006, Circulation.

[36]  C. White,et al.  The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. , 2006, Journal of cardiac failure.

[37]  H. Figulla,et al.  Creatine supplementation improves muscle strength in patients with congestive heart failure. , 2006, Die Pharmazie.

[38]  K. Witte,et al.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives , 2006, Heart Failure Reviews.

[39]  K. Jeejeebhoy,et al.  The management of conditioned nutritional requirements in heart failure , 2006, Heart Failure Reviews.

[40]  M. Lorgeril,et al.  Selenium and antioxidant defenses as major mediators in the development of chronic heart failure , 2006, Heart Failure Reviews.

[41]  B. Kendler.  Supplemental Conditionally Essential Nutrients in Cardiovascular Disease Therapy , 2006, The Journal of cardiovascular nursing.

[42]  M. Sole,et al.  The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. , 2003, Journal of the American College of Cardiology.

[43]  Luca Tiano,et al.  Coenzyme Q 10 and exercise training in chronic heart failure , 2006 .

[44]  M. Gheorghiade,et al.  Non-Invasive Cardiac Evaluation in Heart Failure Patients Using Magnetic Resonance Imaging: A Feasibility Study , 2005, Heart Failure Reviews.

[45]  P. Razeghi,et al.  Cardiac remodeling: UPS lost in transit. , 2005, Circulation research.

[46]  I. Iezhitsa.  Potassium and magnesium depletions in congestive heart failure--pathophysiology, consequences and replenishment. , 2005, Clinical calcium.

[47]  J. Cleland,et al.  The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. , 2005, European heart journal.

[48]  J. Ingwall,et al.  The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. , 2005, Journal of molecular and cellular cardiology.

[49]  C. R. Wilson,et al.  Metabolic Energetics and Genetics in the Heart , 2005, Annals of the New York Academy of Sciences.

[50]  G. Francis,et al.  Neurohormonal upregulation in heart failure. , 2005, Heart failure clinics.

[51]  Joanna M. Young,et al.  Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. , 2005, Atherosclerosis.

[52]  R. Schwinger,et al.  Altered hetero‐ and homeometric autoregulation in the terminally failing human heart , 2005, European journal of heart failure.

[53]  B. Lorell,et al.  Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart , 2004, Hypertension.

[54]  H. Taegtmeyer.  Cardiac metabolism as a target for the treatment of heart failure. , 2004, Circulation.

[55]  M. V. Miles,et al.  Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. , 2004, American journal of clinical pathology.

[56]  J. Cleland,et al.  Are hematinic deficiencies the cause of anemia in chronic heart failure? , 2004, American heart journal.

[57]  G. D’Antona,et al.  Effect of amino acid mixture on the isolated ischemic heart. , 2004, The American journal of cardiology.

[58]  Kamyar Kalantar-Zadeh,et al.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. , 2004, Journal of the American College of Cardiology.

[59]  D. Bello,et al.  Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 2004, The American journal of cardiology.

[60]  H. Löster,et al.  Prolonged Oral L-carnitine Substitution Increases Bicycle Ergometer Performance in Patients with Severe, Ischemically Induced Cardiac Insufficiency , 1999, Cardiovascular Drugs and Therapy.

[61]  R. Ferrari,et al.  Acute and Chronic Effects of Propionyl-L-Carnitine on the Hemodynamics, Exercise Capacity, and Hormones in Patients with Congestive Heart Failure , 1998, Cardiovascular Drugs and Therapy.

[62]  P. H. Langsjoen,et al.  Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment , 2004, The clinical investigator.

[63]  M. Condorelli,et al.  Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study , 2004, The clinical investigator.

[64]  F. D. Lisa,et al.  Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism , 1991, Cardiovascular Drugs and Therapy.

[65]  Dipan J. Shah,et al.  Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.

[66]  E. Park,et al.  Taurine: new implications for an old amino acid. , 2003, FEMS microbiology letters.

[67]  Ewa Witort,et al.  Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property* , 2003, Journal of Biological Chemistry.

[68]  P. Macfarlane,et al.  Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial , 2003, The Lancet.

[69]  J. Azuma,et al.  Possible Cause of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action , 2003, Journal of cardiovascular pharmacology.

[70]  J. Healey,et al.  Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[71]  P. Macdonald,et al.  Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure. , 2003, Heart, lung & circulation.

[72]  S. Mortensen.  Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end‐points of “Q‐symbio” ‐ A multinational trial , 2003, BioFactors.

[73]  P. Langsjoen,et al.  The clinical use of HMG CoA‐reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications , 2003, BioFactors.

[74]  T. Myers,et al.  Reverse Remodeling of the Failing Human Heart with Mechanical Unloading , 2003, Cardiology.

[75]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[76]  Stefan Neubauer,et al.  Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. , 2002, Journal of the American College of Cardiology.

[77]  S. Verma,et al.  Coenzyme Q(10) and congestive heart failure: what is the verdict? , 2002, The Canadian journal of cardiology.

[78]  B. Sarter.  Coenzyme Q10 and cardiovascular disease: a review. , 2002, The Journal of cardiovascular nursing.

[79]  F. Jeejeebhoy,et al.  Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction , 2002 .

[80]  M. Sole,et al.  Conditioned Nutritional Requirements: Therapeutic Relevance to Heart Failure , 2002, Herz.

[81]  O. Frazier,et al.  Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.

[82]  H. Taegtmeyer,et al.  Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. , 2001, Metabolism: clinical and experimental.

[83]  P. Martin,et al.  Molecular mechanisms of thiamine utilization. , 2001, Current molecular medicine.

[84]  F. Dawood,et al.  Conditioned nutritional deficiencies in the cardiomyopathic hamster heart. , 2001, The Canadian journal of cardiology.

[85]  K. Jeejeebhoy,et al.  Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure , 2000, Current opinion in clinical nutrition and metabolic care.

[86]  R. Lerch,et al.  Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. , 2000, Journal of molecular and cellular cardiology.

[87]  A. Hazell,et al.  Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: An in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy , 2000, Journal of neuroscience research.

[88]  I. Rizos.  Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. , 2000, American heart journal.

[89]  B. Rutkowski,et al.  Correlation between Plasma Carnitine, Muscle Carnitine and Glycogen Levels in Maintenance Hemodialysis Patients , 2000, The International journal of artificial organs.

[90]  S. Anker,et al.  Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. , 1999, Chest.

[91]  R. Ferrari.  The Investigators of the Study on Propionyl-L-Carnitine in Chronic Heart Failure , 1999 .

[92]  H. Hansen,et al.  Coenzyme Q10 treatment in serious heart failure , 1999, BioFactors.

[93]  S. Rahimtoola.  Concept and evaluation of hibernating myocardium. , 1999, Annual review of medicine.

[94]  D. Burstow,et al.  Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 1999, Journal of the American College of Cardiology.

[95]  S. Giustiniani,et al.  Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. , 1998, Minerva medica.

[96]  G. Shipley,et al.  Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy , 1998, Nature Medicine.

[97]  N. Sperelakis,et al.  Review of some actions of taurine on ion channels of cardiac muscle cells and others. , 1998, General pharmacology.

[98]  B. Beermann,et al.  No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure , 1997, Journal of internal medicine.

[99]  M. Arsenian.  Carnitine and its derivatives in cardiovascular disease. , 1997, Progress in cardiovascular diseases.

[100]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[101]  A. Zangen,et al.  Thiamine deficiency in cardiac cells in culture. , 1997, Biochemical pharmacology.

[102]  K. Folkers,et al.  Treatment of hypertrophic cardiomyopathy with coenzyme Q10. , 1997, Molecular aspects of medicine.

[103]  S. Mortensen,et al.  Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. , 1997, Molecular aspects of medicine.

[104]  A. Bysted,et al.  Coenzyme Q10 in the diet--daily intake and relative bioavailability. , 1997, Molecular aspects of medicine.

[105]  M. Chiariello,et al.  Hemodynamic effects of creatine phosphate in patients with congestive heart failure: A double‐blind comparison trial versus placebo , 1996, Clinical cardiology.

[106]  W. Vogel,et al.  Levels of taurine, amino acids and related compounds in plasma, vena cava, aorta and heart of rats after taurine administration. , 1996, Pharmacology.

[107]  G. Lopaschuk,et al.  Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. , 1995, Circulation research.

[108]  C. Sylvén,et al.  Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. , 1995, Cardiovascular research.

[109]  F. L. Crane,et al.  Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  M. Motro,et al.  Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. , 1995, The American journal of medicine.

[111]  C. Rock,et al.  Thiamin status, diuretic medications, and the management of congestive heart failure. , 1993, Journal of the American Dietetic Association.

[112]  H. Taegtmeyer,et al.  Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. , 1995, The American journal of physiology.

[113]  H. Taegtmeyer.  Energy metabolism of the heart: from basic concepts to clinical applications. , 1994, Current problems in cardiology.

[114]  K. Folkers,et al.  Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. , 1994, Molecular aspects of medicine.

[115]  V. Ganapathy,et al.  Expression and regulation of the taurine transporter in cultured cell lines of human origin. , 1994, Advances in experimental medicine and biology.

[116]  J. Guilland,et al.  Thiamine status of elderly patients with cardiac failure including the effects of supplementation. , 1994, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[117]  F. L. Crane,et al.  Coenzyme Q10, plasma membrane oxidase and growth control. , 1994, Molecular aspects of medicine.

[118]  M. Passeri,et al.  Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. , 1994, Molecular aspects of medicine.

[119]  S. Jameson.  Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities , 1993, The Clinical investigator.

[120]  P. Harper,et al.  Carnitine measurements in liver, muscle tissue, and blood in normal subjects. , 1993, Clinical chemistry.

[121]  P. Fenster,et al.  Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study. , 1993, Journal of the American College of Cardiology.

[122]  G. Littarru,et al.  Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study , 1993, Journal of clinical pharmacology.

[123]  T. Yoshida,et al.  Reactivity of taurine with aldehydes and its physiological role. , 1993, Chemical & pharmaceutical bulletin.

[124]  R. Grimble,et al.  Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet. , 1992, The Journal of nutrition.

[125]  F. Rengo,et al.  Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure. , 1992, Arzneimittel-Forschung.

[126]  J. Azuma,et al.  Usefulness of taurine in chronic congestive heart failure and its prospective application. , 1992, Japanese circulation journal.

[127]  K. Folkers,et al.  Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant. , 1992, Biochemical and biophysical research communications.

[128]  J. Potter,et al.  Thiamine status of elderly patients with cardiac failure. , 1992, Age and ageing.

[129]  M. Motro,et al.  Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. , 1991, The American journal of medicine.

[130]  A. Kobayashi,et al.  Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure. , 1990, Japanese circulation journal.

[131]  C. Reggiani,et al.  Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation. , 1990, Journal of molecular and cellular cardiology.

[132]  M. Fisher,et al.  Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. , 1990, Journal of the American College of Cardiology.

[133]  E. Fleck,et al.  Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. , 1990, The American journal of cardiology.

[134]  J. Azuma,et al.  Reduction of doxorubicin-induced cardiotoxicity in mice by taurine. , 1988, Research communications in chemical pathology and pharmacology.

[135]  R. Simpson,et al.  Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.

[136]  M. Mozaffari,et al.  Potentiation of myocardial ischemic injury by drug-induced taurine depletion. , 1987, Advances in experimental medicine and biology.

[137]  G. Miotto,et al.  Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia. , 1987, Zeitschrift fur Kardiologie.

[138]  J. Azuma,et al.  Beneficial effect of taurine in rabbits with chronic congestive heart failure. , 1986, American heart journal.

[139]  H. Taegtmeyer.  Carbohydrate interconversions and energy production. , 1985, Circulation.

[140]  K. Folkers,et al.  Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[141]  K. Folkers,et al.  Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[142]  Y. Ostrovsky,et al.  THIAMIN PYROPHOSPHOKINASE: STRUCTURE, PROPERTIES. AND ROLE IN THIAMIN METABOLISM * , 1982, Annals of the New York Academy of Sciences.

[143]  J. Kramer,et al.  Effect of taurine on calcium paradox and ischemic heart failure. , 1981, The American journal of physiology.

[144]  A. Barbeau,et al.  Taurine Decreases Lesion Severity In the Hearts of Cardiomyopathy Hamsters , 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[145]  C. Kawai,et al.  Furosemide-induced thiamine deficiency. , 1980, Cardiovascular research.

[146]  J. Chubb,et al.  Physiological and experimental regulation of taurine content in the heart. , 1980, Federation proceedings.

[147]  J. Kramer,et al.  Regulation of calcium homeostasis in the heart by taurine. , 1980, Federation proceedings.

[148]  H A Krebs,et al.  Utilization of energy-providing substrates in the isolated working rat heart. , 1980, The Biochemical journal.

[149]  W. Abelmann,et al.  Cardiovascular effects of exercise in hamsters with experimental thiamine deficiency. , 1979, Japanese circulation journal.

[150]  P. Dreyfus.  Nutritional Disorders of the Nervous System , 1979 .

[151]  J. Lombardini,et al.  Loss of cardiac muscle taurine after acute left ventricular ischemia. , 1977, Life sciences.

[152]  W. Abelmann,et al.  Mechanical properties of rat cardiac muscle during experimental thiamine deficiency. , 1976, The American journal of physiology.

[153]  H. Iwata.  Catecholamine metabolism in thiamine-deficient rats. , 1976, Journal of nutritional science and vitaminology.

[154]  S. Toyama,et al.  A clinical study of the effect of coenzyme Q on congestive heart failure. , 1976, Japanese heart journal.

[155]  S. Yamashita.  Relationship between thiamine deficient cardiac lesions and myocardial and blood pyruvic acid contents. , 1971, Japanese heart journal.

[156]  M. Davies,et al.  The ultrastructure of the myocardium in the thiamine‐deficient rat , 1970, The Journal of pathology.

[157]  E. E. Aldinger,et al.  Effect of Thiamine Deficiency on Potential Myocardial Contractility , 1965, Circulation research.

[158]  D. Boullin.  Pharmacological responses of thiamine-deficient rat tissues. , 1963, British journal of pharmacology and chemotherapy.

[159]  Y. Yoshitoshi,et al.  Experimental studies on the beriberi heart. I. Cardiac lesions in thiamine deficient rats. , 1961, Japanese heart journal.

[160]  W. Schwartz,et al.  Myocardial metabolism in congestive heart failure. , 1951, Medicine.